SCHEPIS, Filippo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.401
EU - Europa 3.144
AS - Asia 1.118
SA - Sud America 42
AF - Africa 24
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.745
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.382
GB - Regno Unito 1.143
IT - Italia 743
SE - Svezia 453
CN - Cina 433
DE - Germania 298
HK - Hong Kong 237
SG - Singapore 201
UA - Ucraina 152
TR - Turchia 92
BG - Bulgaria 86
FI - Finlandia 76
FR - Francia 47
ID - Indonesia 42
VN - Vietnam 32
LT - Lituania 23
RU - Federazione Russa 23
BR - Brasile 19
BE - Belgio 17
IN - India 17
EG - Egitto 16
MY - Malesia 14
RO - Romania 14
ES - Italia 13
CA - Canada 12
NL - Olanda 11
AU - Australia 9
IE - Irlanda 9
KR - Corea 9
CZ - Repubblica Ceca 8
CO - Colombia 7
CL - Cile 6
EU - Europa 6
PE - Perù 6
SC - Seychelles 6
JP - Giappone 5
BZ - Belize 4
CH - Svizzera 4
PL - Polonia 4
SI - Slovenia 4
TH - Thailandia 4
GR - Grecia 3
HR - Croazia 3
IL - Israele 3
NP - Nepal 3
PH - Filippine 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BO - Bolivia 2
EE - Estonia 2
GE - Georgia 2
HU - Ungheria 2
IR - Iran 2
LV - Lettonia 2
MX - Messico 2
QA - Qatar 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BA - Bosnia-Erzegovina 1
EC - Ecuador 1
IM - Isola di Man 1
JO - Giordania 1
KW - Kuwait 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
PA - Panama 1
SA - Arabia Saudita 1
TM - Turkmenistan 1
TN - Tunisia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 11.745
Salva come PNG Salva come JPEG
Città #
Fairfield 1.227
Southend 972
Woodbridge 726
Ashburn 642
Chandler 600
Houston 562
Seattle 476
Cambridge 415
Wilmington 405
Ann Arbor 327
Nyköping 322
Jacksonville 309
Modena 302
Dearborn 255
Hong Kong 236
Singapore 128
San Diego 118
Beijing 113
Princeton 96
Sofia 86
New York 76
Izmir 71
Eugene 56
Redwood City 50
London 46
Jakarta 42
Helsinki 40
Grafing 39
Shanghai 36
Des Moines 31
Milan 30
Bologna 28
Nanjing 27
Bremen 26
Boardman 22
Falls Church 22
Guangzhou 21
Brussels 17
Hefei 16
Wuhan 16
Hanoi 15
Chicago 13
Jinan 12
Norwalk 12
Dong Ket 11
Rome 11
Dublin 9
Kilburn 9
Carpi 8
Chiswick 8
Kunming 8
Los Angeles 8
Saint Petersburg 8
San Jose 8
Brno 7
Fremont 7
Munich 7
Napoli 7
Padova 7
Prescot 7
Rho 7
Augusta 6
Bari 6
Cairo 6
Castelnuovo Rangone 6
Dallas 6
Ferrara 6
Hounslow 6
Mahé 6
Mumbai 6
Wenzhou 6
Andover 5
Florence 5
Frankfurt am Main 5
Kuala Lumpur 5
Lappeenranta 5
Ottawa 5
San Mateo 5
Seongnam 5
Sydney 5
Tanta 5
Timisoara 5
Verona 5
Acton 4
Baotou 4
Belize City 4
Buffalo 4
Council Bluffs 4
Lecce 4
Legnaro 4
Mariano Comense 4
Mountain View 4
Naples 4
Palo Alto 4
Paris 4
Piacenza 4
Rimini 4
Romainville 4
Roncoferraro 4
Sassuolo 4
Totale 9.406
Salva come PNG Salva come JPEG
Nome #
Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease 543
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 301
Liver Angiopoietin-2 is a key predictor of de novo or recurrent hepatocellular cancer after HCV direct-acting antivirals 299
Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study 275
PROGRESSIVE ALTERATIONS IN SYSTEMIC AND CARDIOPULMONARY HEMODYNAMICS OCCUR IN PATIENTS WITH CIRRHOSIS AND PREDICT DEATH IN DECOMPENSATED CIRRHOSIS 242
ANTICOAGULANT THERAPY IS SAFE AND EFFECTIVE IN PREVENTING PORTAL VEIN THROMBOSIS (PVT) IN ADVANCED CIRRHOTIC PATIENTS: A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 232
Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis 220
Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis 218
Cardiopulmonary hemodynamics and c-reactive protein as prognostic indicators in compensated and decompensated cirrhosis 216
A new device for ultrasound-guided peripheral venous access 213
Consensus conference on TIPS management: Techniques, indications, contraindications 191
Q-T interval prolongation in cirrhosis: prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors. 179
Unusual association between Budd–Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: a case report and review of the literature 178
Liver steatosis and non-alcoholic fatty liver disease with fibrosis are predictors of frailty in people living with HIV 177
Cloning and molecular characterization of a novel gene strongly induced by the adenovirus E1A gene in rat thyroid cells. 174
Obese zebrafish: A small fish for a major human health condition 174
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference 173
De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients 171
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias 170
Low molecular weight heparin does not increase bleeding and mortality post endoscopic variceal band ligation in cirrhotic patients 170
ENOXAPARIN PREVENTS PORTAL VEIN THROMBOSIS (PVT) AND DECOMPENSATION IN ADVANCED CIRRHOTIC PATIENTS: FINAL REPORT OF A PROSPECTIVE RANDOMIZED CONTROLLED STUDY 170
30 Days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice. 167
Complete resolution of non-necrotizing lung granuloma and pyoderma gangrenosum after restorative proctocolectomy in a woman with severe ulcerative colitis and cytomegalovirus infection 166
Validating, deconstructing and refining Baveno criteria for ruling out high-risk varices in patients with compensated cirrhosis 165
Ccdc80-l1 Is involved in axon pathfinding of zebrafish motoneurons. 165
Prevention and Management of Bleeding Risk Related to Invasive Procedures in Cirrhosis 164
PROCALCITONIN IS THE BEST DIAGNOSTIC AND PROGNOSTIC MARKER OF SEPSIS IN DECOMPENSATED CIRRHOTIC PATIENTS 163
JLB: a flexible and effective device in critical patients. Review of clinical cases 163
A RANDOMIZED TRIAL OF THE SAFETY AND HEPATIC HEMODYNAMIC EFFECTS OF INTRAVENOUS CONIVAPTAN IN EUVOLEMIC OR HYPERVOLEMIC CIRRHOTIC PATIENTS 161
Thrombophilic genetic risk factors for liver fibrosis: To screen or not to screen? 160
Reply to: “Relationship of hyperdynamic circulation and cardiodynamic states in cirrhosis” 151
Study of the Serum Metabolomic Profile in Nonalcoholic Fatty Liver Disease: Research and Clinical Perspectives 150
Effect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data. 149
Hemodynamic response to propranolol in patients with recurrent hepatitis C virus-related cirrhosis after liver transplantation: A case-control study 148
Paradoxical embolization in TIPS: take a closer look to the heart 147
LOW MOLECULAR WEIGHT HEPARIN TREATMENT DOES NOT INCREASE THE RISK OF BLEEDING AFTER PROPHYLACTIC ENDOSCOPIC VARICEAL BAND LIGATION IN PATIENTS WITH CIRRHOSIS 147
Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? 146
Loss of the tumor suppressor gene PTEN marks the transition from intratubular germ cell neoplasias (ITGCN) to invasive germ cell tumors. 145
The base excision repair enzyme MED1 mediates DNA damage response to antitumor drugs and is associated with mismatch repair system integrity. 144
Chemoprevention of hepatocellular carcinoma 142
Effects of simvastatin treatment on sICAM-1 and sE-selectin levels in hypercholesterolemic subjects. 140
Retreatment with interferon plus ribavirin of chronic hepatitis C non-responders to interferon monotherapy: a meta-analysis of individual patient data. 136
Transjugular intrahepatic portosystemic shunt does not affect the efficacy and safety of direct-acting antivirals in patients with advanced cirrhosis: a real-life, case-control study 134
Protection of human endothelial cells from oxidative stress: Role of Ras-ERK1/2 signaling 130
Outcome of liver disease and response to interferon treatment are not influenced by hepatitis B virus core gene variability in children with chronic type B hepatitis. 129
Guide-wire replacement of a mini-midline catheter with a central venous catheter: A retrospective study on 63 cases 127
The Coiled-Coil Domain Containing 80 (ccdc80) gene regulates gadd45β2 expression in the developing somites of zebrafish as a new player of the hedgehog pathway 125
MED1, a novel human methyl-CpG-binding endonuclease, interacts with DNA mismatch repair protein MLH1 122
Transarterial chemoembolization for unresectable hepatocellular carcinoma: Meta-analysis of randomized controlled trials 122
Angiopoietin-2/Tie2 Inhibition by Regorafenib Associates With Striking Response in a Patient With Aggressive Hepatocellular Carcinoma 122
Preoperative chemoradiotherapy for oesophageal cancer: A systematic review and meta-analysis 120
When and how to treat acute hepatitis C? 118
Pre-transplant diabetes predicts atherosclerotic vascular events and cardiovascular mortality in liver transplant recipients: a long-term follow-up study 107
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 106
An adenovirus carrying the rat protein tyrosine phosphatase eta suppresses the growth of human thyroid carcinoma cell lines in vitro and in vivo. 99
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosis 97
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 97
Pathophysiology of portal hypertension and variceal bleeding 96
Meta-analysis of Transarterial Embolization in Patients with Unresectable Hepatocellular Carcinoma: Dr Camma and colleagues respond 96
Alcoholic and Nonalcoholic Liver Disease: Diagnostic Assessment and Therapeutic Perspectives 93
Natural history of chronic HBV in northern Italy: Morbidity and morality after 30 years 88
Tumor suppressor role of the CL2/DRO1/CCDC80 gene in thyroid carcinogenesis 86
Transient elastography and ultrasonography: Optimal evaluation of liver fibrosis and cirrhosis in patients with chronic hepatitis B concurrent with nonalcoholic fatty liver disease 81
Prevalence, Predictors, and Severity of Lean Nonalcoholic Fatty Liver Disease in Patients Living With Human Immunodeficiency Virus 79
Akt1/Akt2 inhibition and development of hepatocellular carcinoma 74
Baveno VII – Renewing consensus in portal hypertension 74
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 73
Transjugular intrahepatic portosystemic shunt (TIPS): current indications and strategies to improve the outcomes 72
The OMICs window into nonalcoholic fatty liver disease (NAFLD) 72
Monitoring Treatment of Cirrhosis and Portal Hypertension 69
Prediction of Esophageal Varices by Liver Stiffness and Platelets in Persons with HIV infection and Compensated Advanced Chronic Liver Disease 69
Reply to: “It takes two “eyes” to see in depth” 66
Cardiodynamic state is associated with systemic inflammation and fatal acute-on-chronic liver failure 64
The role of transjugular intrahepatic portosystemic shunt in patients with cirrhosis and ascites: Recent evolution and open questions 63
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF) 60
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 53
Baveno IV Consensus Statements: Predictive Models in Portal Hypertension 52
Relevance of spontaneous portosystemic shunts detected with CT in patients with cirrhosis 50
Retraction: The OMICs Window into Nonalcoholic Fatty Liver Disease (NAFLD) (Metabolites 2019, 9(2), 25) 47
Controlled underdilation using novel VIATORR® controlled expansion stents improves survival after transjugular intrahepatic portosystemic shunt implantation 46
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma 44
Proximal Splenic Artery Embolization to Treat Refractory Ascites in a Patient With Cirrhosis 44
Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation 43
Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension 41
Reply to: “The clinical advantage of fixed 8-mm diameter VCX stents over underdilated VTS stents is not established in refractory ascites” 41
Portosystemic shunt is an effective treatment for complications of portal hypertension in hepatic myeloid metaplasia and improves nutritional status 40
Decompensation in Advanced Nonalcoholic Fatty Liver Disease May Occur at Lower Hepatic Venous Pressure Gradient Levels Than in Patients With Viral Disease 39
Mortality after transjugular intrahepatic portosystemic shunt in older adult patients with cirrhosis: A validated prediction model 35
The use of intrahepatic portosystemic shunt in HIV positive patients: A retrospective multicentric study 32
Assessment of portal hypertension severity using machine learning models in patients with compensated cirrhosis 29
Upregulation of the oestrogen target gene SIX1 is associated with higher growth speed and decreased survival in HCV-positive women with hepatocellular carcinoma 27
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study 24
Endoscopic radiofrequency ablation for the treatment of severe gastric antral vascular ectasia in patients with cirrhosis 23
GALAD outperforms aMAP and ALBI for predicting HCC in patients with compensated advanced chronic liver disease: A 12-year prospective study 21
Erratum: Alcoholic and nonalcoholic liver disease: Diagnostic assessment and therapeutic perspectives (BioMed Research International (2019) 2019 (8691502) DOI: 10.1155/2019/8691502) 18
Endovascular Assessment of Liver Hemodynamics in Patients with Cirrhosis Complicated by Portal Hypertension 17
Angiopoietin-2 and the Vascular Endothelial Growth Factor Promote Migration and Invasion in Hepatocellular Carcinoma- and Intrahepatic Cholangiocarcinoma-Derived Spheroids 15
Reply 14
Correction: The Role of Anticoagulation in Treating Portal Hypertension 14
Reply 12
Totale 11.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.215
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.215
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.083 0 0 88 175 238 402 383 235 236 108 122 96
2020/20212.531 132 156 204 313 339 221 157 288 109 325 183 104
2021/20221.883 132 156 157 66 76 111 132 158 213 148 321 213
2022/20231.751 216 209 140 164 156 261 21 179 183 29 129 64
2023/20241.173 51 63 79 120 185 91 154 114 66 21 91 138
2024/2025226 139 66 21 0 0 0 0 0 0 0 0 0
Totale 11.953